Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 5Hepatitis B, Chronic 3Hepatitis B 3Lymphoma 2Virus Diseases 1Recurrence 1Paraparesis, Tropical Spastic 1Neuritis 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1Infections 1HTLV-I Infections 1Fibrosis 1Epstein-Barr Virus Infections 1Burkitt Lymphoma 1

Interventions

Tenofovir 3peginterferon alfa-2b 2peginterferon alfa-2a 1ibrutinib 1entecavir 1durvalumab 1babao dan 1Radiofrequency Ablation 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hepatitis B, Chronic × Tenofovir × Clear all
NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02081469 2020-02-05

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Chang Gung Memorial Hospital

Phase 4 Completed
100 enrolled

Neoplasms, Hepatitis B, Chronic

NCT01872988 2014-09-04

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Taichung Veterans General Hospital

Phase 3 Terminated
320 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡